Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy
Xuyong Zheng, Chuchu Sun, Qian Liu, Xiaoyao Lu, Lili Fu, Guang Liang, Xiuhua Zhang, Gaozhi Chen
Topics & Concepts
InflammationTLR4FibrosisProinflammatory cytokineMedicinePharmacologyCardiomyopathyCardiac fibrosisMyocardial fibrosisEndocrinologyInternal medicineHeart failureCardiac Fibrosis and RemodelingIL-33, ST2, and ILC PathwaysAdipokines, Inflammation, and Metabolic Diseases